APP and Alzheimer disease: Studies from Branca and colleagues also performed in APP/PS1 mice, a transgenic mice strain that produces an excess of β-amyloid plaques and cognitive impairment, showed a decrease in Nrf2 activity and significant reduction in HO-1 levels concomitantly with AD pathology and cognitive impairment [17].